【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Disease overview
• Understanding the disease
• Economic burden
• Types of lung cancer
• Diagnosis
• Staging of SCLC
• Staging of NSCLC
• Key buying criteria
PART 06: Pipeline analysis
PART 07: Market landscape
• Global lung cancer therapeutics market
• Five forces analysis
PART 08: Market segmentation by disease type
• NSCLC
• Global NSCLC market overview
• SCLC
• Global SCLC market overview
PART 09: Market segmentation by type of molecule
• Small molecules
• Biologics
PART 10: Geographical segmentation
• Lung cancer therapeutics market in Americas
• Lung cancer therapeutics market in EMEA
• Lung cancer therapeutics market in APAC
PART 11: Market drivers
• Growing demand for targeted therapies
• Presence of blockbuster drugs coupled with longer patent exclusivities
• Advancements in identification of molecular biomarkers increasing patient pool
• Paradigm shifts toward the adoption of checkpoint inhibitors
PART 12: Impact of drivers
PART 13: Market challenges
• Growing popularity of alternative therapeutics
• High costs leading to low adoption rate
• Adverse effects of drugs
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Emergence of nanomedicine platform for the treatment of lung cancer
• Advent of miRNA therapeutics in the treatment of lung cancer
• Growing strategic alliances for late-stage pipeline
• Growing approvals in lung cancer therapeutics market
PART 16: Vendor landscape
• Competitive scenario
PART 17: Key vendor analysis
• F. Hoffmann-La Roche
• Eli Lilly
• AstraZeneca
• Pfizer
• Celgene
• Other prominent vendors
PART 18: Appendix
• List of abbreviations
PART 19: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key customer segments of global lung cancer therapeutics market
Exhibit 03: Snapshot of lung cancer
Exhibit 04: Types of lung cancer
Exhibit 05: Main diagnostic procedures to determine presence of lung cancer
Exhibit 06: Staging of SCLC
Exhibit 07: Illustration of stages of NSCLC disease
Exhibit 08: Key buying criteria for lung cancer therapeutics
Exhibit 09: Factors affecting adoption rates of lung cancer therapeutics
Exhibit 10: Pipeline analysis of key vendors in global lung cancer therapeutics market
Exhibit 11: Percentage share of drug candidates by stage of development
Exhibit 12: Phase III pipeline portfolio: Global lung cancer therapeutics market
Exhibit 13: Phase II pipeline portfolio: Global lung cancer therapeutics market
Exhibit 14: Phase I pipeline portfolio: Global lung cancer therapeutics market
Exhibit 15: Global lung cancer therapeutics market snapshot
Exhibit 16: Analysis of global lung cancer therapeutics market
Exhibit 17: Global lung cancer therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 18: Opportunity analysis of global lung cancer therapeutics market
Exhibit 19: Opportunity analysis in developed and emerging markets
Exhibit 20: Five forces analysis
Exhibit 21: Segmentation of global lung cancer therapeutics market by disease type 2015 and 2020
Exhibit 22: Life cycle analysis of key segments in global lung cancer therapeutics market 2015
Exhibit 23: Types of NSCLC
Exhibit 24: Potential drugs/drug candidates in global NSCLC therapeutics market
Exhibit 25: Key drivers impacting market growth in NSCLC
Exhibit 26: Global NSCLC therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 27: Opportunity analysis in global NSCLC market
Exhibit 28: Key points in SCLC
Exhibit 29: Key drivers impacting market growth in SCLC
Exhibit 30: Global SCLC therapeutics market size and forecast 2015-2020 ($ billions)
Exhibit 31: Opportunity analysis in global SCLC therapeutics market
Exhibit 32: Segmentation of global lung cancer therapeutics market by type of molecule 2015
Exhibit 33: Global lung cancer therapeutics market by geographical segmentation 2015-2020
Exhibit 34: Segmentation of global lung therapeutics market based on geography 2015 and 2020
Exhibit 35: Lung cancer therapeutics market revenue by geography 2015-2020 ($ billions)
Exhibit 36: Lung cancer therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 37: Key trends across various countries in Americas
Exhibit 38: Lung cancer therapeutics market size and forecast in EMEA 2015-2020 ($ billions)
Exhibit 39: Drivers in lung cancer therapeutics market in EMEA
Exhibit 40: Key strategic initiatives in various countries in EMEA
Exhibit 41: Lung cancer therapeutics market size and forecast in APAC 2015-2020 ($ billions)
Exhibit 42: Key drivers and challenges in APAC
Exhibit 43: YoY growth rate of Avastin 2015
Exhibit 44: Performance of blockbuster drugs in 2015
Exhibit 45: Patent exclusivities of few blockbuster drugs
Exhibit 46: Recent launches of checkpoint inhibitors
Exhibit 47: Impact of drivers
Exhibit 48: Alternative therapies for lung cancer therapeutics
Exhibit 49: Costs of few lung cancer drugs ($)
Exhibit 50: Force field analysis of drivers and challenges in global lung cancer therapeutics market
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Trend analysis in global lung cancer therapeutics market
Exhibit 53: Key factors driving adoption of nanomedicine
Exhibit 54: Factors driving adoption of miRNA therapeutics
Exhibit 55: Key deals in global lung cancer therapeutics market
Exhibit 56: Recent approvals of lung cancer therapeutics
Exhibit 57: Competitive analysis in global lung cancer therapeutics market
Exhibit 58: Market penetration of various lung cancer therapeutics manufacturers in global (2015)
Exhibit 59: Regional analysis of vendors in global lung cancer therapeutics market
Exhibit 60: Vendors ranking in global lung cancer therapeutics market
Exhibit 61: F. Hoffmann-La Roche: Key highlights
Exhibit 62: F. Hoffmann-La Roche: Strength assessment
Exhibit 63: F. Hoffmann-La Roche: Strategy assessment
Exhibit 64: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 65: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2013-2015 ($ billions)
Exhibit 66: F. Hoffmann-La Roche: Geographic segmentation of Avastin by revenue 2015
Exhibit 67: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Tarceva 2013-2015 ($ billions)
Exhibit 68: F. Hoffmann-La Roche: Geographic segmentation of Tarceva by revenue 2015
Exhibit 69: Eli Lilly: Key highlights
Exhibit 70: Eli Lilly: Strength assessment
Exhibit 71: Eli Lilly: Strategy assessment
Exhibit 72: Eli Lilly: Opportunity assessment
Exhibit 73: Eli Lilly: YoY revenue and growth rate of Alimta 2013-2015 ($ billions)
Exhibit 74: Eli Lilly: Geographic segmentation by revenue of Alimta 2015
Exhibit 75: Eli Lilly: YoY and growth rate of Cyramza 2014-2015 ($ millions)
Exhibit 76: Eli Lilly: Geographic segmentation by revenue of Cyramza 2015
Exhibit 77: AstraZeneca: Key highlights
Exhibit 78: AstraZeneca: Strength assessment
Exhibit 79: AstraZeneca: Strategy assessment
Exhibit 80: AstraZeneca: Opportunity assessment
Exhibit 81: AstraZeneca: YoY revenue and growth rate of Iressa 2013-2015 ($ billions)
Exhibit 82: AstraZeneca: Geographic segmentation of Iressa 2013-2015 (% share)
Exhibit 83: Pfizer: Key highlights
Exhibit 84: Pfizer: Strength assessment
Exhibit 85: Pfizer: Strategy assessment
Exhibit 86: Pfizer: Opportunity assessment
Exhibit 87: Pfizer: YoY revenue and growth rate of Xalkori 2013-2015 ($ millions)
Exhibit 88: Celgene: Key highlights
Exhibit 89: Celgene: Strength assessment
Exhibit 90: Celgene: Strategy assessment
Exhibit 91: Celgene: Opportunity assessment
Exhibit 92: Celgene: YoY revenue and growth rate of Abraxane 2013-2015 ($ millions)
【レポート販売概要】
■ タイトル：肺がん治療薬の世界市場2016-2020：NSCLC、SCLC■ 英文：Global Lung Cancer Therapeutics Market 2016-2020
■ 発行日：2016年11月18日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10849
■ 調査対象地域：グローバル
- 構内配線の世界市場2019-2023About this market Integrated building management system to drive market growth. An integrated building management system (BMS) is a type of master control system that combines every mechanical, electrical, security, and communication systems within a facility into a single unified system. This enables them to exchange information with each other and work together seamlessly. Such a system makes th …
- 世界のスマートグリッド・マネージドサービス市場動向（2012-2016）TechNavio's analysts forecast the Global Smart Grid Managed Services market to grow at a CAGR of 51.29 percent over the period 2012-2016. One of the key factors contributing to this market growth is the emergence of smart grids. The Global Smart Grid Managed Services market has also been witnessing an increasing support for the Smart Grid industry from numerous governments. However, the commercial …
- OLED照明の世界市場2015-2022A year ago the outlook for OLED lighting seemed to brighten a bit, anticipating that new capacity build-outs and continued development would enable higher outputs and lower costs, and finally start to unlock broad market demand. Unfortunately these efforts largely haven't panned out: LG Chem has pushed out its planned expansion, Konica Minolta did ramp but we believe with disappointing results so …
- 海洋用電気自動車の世界市場2016-2020About the Marine Electric Vehicles Market The adoption of electric vehicles has increased considerably as they produce lower carbon emissions than fuel-powered vehicles. In addition, scarcity of fuel reserves has shifted the demand for the use of alternative energy sources, which in turn, propels the ships and boats market. There are three types of electric vehicles, which are as follows: • Batter …
- ピコ・プロジェクターの世界市場2015-2019About Pico Projector A projector is a portable optical device that projects images on any surface or screen. Traditional projector and pico projector are the two types of projector available; the latter is preferred over the former for its small size, light weight, and easy portability. There are two types of pico projector available in the market: standalone and embedded. Technavio's analysts for …
- アンモニア、無水・水溶液市場：インドThis report is a comprehensive research of ammonia, anhydrous and in aqueous solution market in India. The report starts with giving brief country profile for India, including general information and main economic indicators. Further, the report provides in-depth analyses ammonia, anhydrous and in aqueous solution market in the country. It identifies key market players, including major producers, …
- タイル接着剤の世界市場予測Tile adhesive is used to join two substrates and offer excellent chemical resistance, shock & impact resistance, high bond strength, and ultimate flexibility. The tile adhesive works on the basis of cohesive mechanisms and adhesion mechanisms.The tile adhesive market across the world is expected to reach USD 3338.2 million by the end of 2023. The growth of the tile adhesive market can be attribute …
- 2型糖尿病：企業と競争環境PharmaPoint: Type 2 Diabetes - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Type 2 Diabetes - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Type 2 Diabetes Market. The report identifies and analyses the key companies shaping and driving the global Type …
- 粒径分析の世界市場：レーザー回折、DLS（動的光散乱）、撮像（動的、静的）、コールター原理、NTA（ナノ粒子追尾解析）Particle size analysis or particle size measurement is a technique to determine the size and shape of the particles in the liquid or powder sample. Particle size analyzers are extensively used in formulating and manufacturing of products in several industries such as pharmaceuticals, chemicals & petroleum, mining, minerals & cement, and food & beverage, among others. The particle size analysis mar …
- 食品検査システムの世界市場2015-2022According to Stratistics MRC, the Global Food Diagnostics Systems market is poised to grow at a CAGR of 9.5% during the forecast period. Food Diagnostics has been in market since last couple of years, but rising awareness towards food safety nowadays is acting as a catalyst to market. The advancement in diagnostic technologies for detecting the food contaminants are further driving the market grow …
- TSHの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of TSH testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC/Dec …
- 鼡径ヘルニア(Inguinal Hernia)：世界の治験レビュー（2015年上半期版）Inguinal Hernia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Inguinal Hernia Global Clinical Trials Review, H1, 2015" provides an overview of Inguinal Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Inguinal Hernia. Report includes an overview of trial numbers and their average enrollment in top countrie …
- 乗用車用交換タイヤの世界市場2016-2020Advances in tire technology continued with the advent of new and existing companies. Present day tire vendors manufacture tires to suit the needs of multiple automobile classes and hence, the market is segmented in terms of application and technology. There are specific tires for definite weather conditions, including all-season, winter, and summer tires. There is a broad spectrum of both global a …
- 3PL（サードパーティーロジスティクス）の日本市場2017-2021About Third-Party LogisticsThe term 3PL refers to third-party logistics that essentially involves a vendor catering to the logistics and distribution management of outsourced products and services of different companies. Shippers (customers, who transport goods using 3PL services) outsource some or all the supply chain management (SCM) functions of their logistics services to the 3PL provider. The …
- カーボンブラック(BC)の世界市場予測Carbon Black (BC) 2013 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about carbon black market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical …
